The results obtained so far implicate that BCL9L is involved in the regulation of EMT in pancreatic cancer cells, as its knockdown induced up-regulation of the epithelial marker protein E-cadherin accompanied by increased cell-cell adhesion. This evidence concerns the gene BCL9L and familial pancreatic carcinoma.